Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
freegriff's Profile
Displaying 1-50 of 1557 result(s).
AMBS Amarantus Bioscience Holdings
10/16/2025 9:36:50 AM
New MANF research from our Finnish (2)
AMBS Amarantus Bioscience Holdings
08/20/2025 8:49:21 PM
I see a Bonum SPAC and all I can th (1)
AMBS Amarantus Bioscience Holdings
08/20/2025 8:46:47 PM
Mentions MANF since it's so closely (1)
AMBS Amarantus Bioscience Holdings
08/17/2025 8:48:45 PM
On X just now: @g_commish: "Tollovi (2)
AMBS Amarantus Bioscience Holdings
07/31/2025 9:47:12 AM
New study for MANF in heart disease (3)
AMBS Amarantus Bioscience Holdings
07/30/2025 10:52:19 PM
Very strong new study on MANF in ag (3)
AMBS Amarantus Bioscience Holdings
06/27/2025 4:14:04 PM
New MANF research related to gettin (2)
AMBS Amarantus Bioscience Holdings
06/04/2025 2:10:26 PM
New MANF research on use as a bioma (2)
AMBS Amarantus Bioscience Holdings
05/30/2025 6:18:23 AM
New research: MANF in Alzheimer's, (3)
AMBS Amarantus Bioscience Holdings
05/06/2025 8:07:22 PM
TylerDurden Now that's a name I've
AMBS Amarantus Bioscience Holdings
05/04/2025 8:37:32 PM
New Chinese MANF research in Retini (2)
AMBS Amarantus Bioscience Holdings
05/02/2025 10:33:40 PM
29900% lol gtfoh
AMBS Amarantus Bioscience Holdings
04/23/2025 2:57:54 PM
To the market makers, speculators, (2)
AMBS Amarantus Bioscience Holdings
04/23/2025 2:56:16 PM
No other stockholders get +9900% da (1)
AMBS Amarantus Bioscience Holdings
04/14/2025 12:13:55 PM
New MANF research in Nature for Pne (3)
AMBS Amarantus Bioscience Holdings
04/07/2025 11:49:08 PM
New MANF therapy for Peripheral Ner (4)
AMBS Amarantus Bioscience Holdings
03/08/2025 11:19:51 PM
New MANF research in diabetes and m (5)
AMBS Amarantus Bioscience Holdings
03/01/2025 11:16:50 AM
Latest newsletter from Snow Foundat (2)
AMBS Amarantus Bioscience Holdings
02/24/2025 8:55:17 AM
Love that he's chatting but makes m (2)
AMBS Amarantus Bioscience Holdings
02/22/2025 11:35:37 PM
5 count em 5! New MANF research art (3)
AMBS Amarantus Bioscience Holdings
02/22/2025 11:13:16 PM
Dr. Urano will be on the steering C (1)
AMBS Amarantus Bioscience Holdings
02/21/2025 5:36:06 PM
6.63M volume day. Is this for real? (1)
AMBS Amarantus Bioscience Holdings
02/20/2025 9:41:53 AM
New from Nature: MANF and a form of (2)
AMBS Amarantus Bioscience Holdings
02/09/2025 11:17:28 AM
Big for us. Reduces risk. First bra (2)
AMBS Amarantus Bioscience Holdings
01/27/2025 5:33:22 AM
Nature has a new AI guided research (2)
AMBS Amarantus Bioscience Holdings
01/07/2025 10:28:34 AM
MANF and PFAS (the forever chemical (3)
AMBS Amarantus Bioscience Holdings
12/20/2024 10:12:43 AM
First news article on MANF I've see (3)
AMBS Amarantus Bioscience Holdings
12/10/2024 6:53:44 PM
New MANF research in Sepsis-associa (3)
AMBS Amarantus Bioscience Holdings
11/27/2024 4:27:00 PM
Happy Thanksgiving everyone! (2)
AMBS Amarantus Bioscience Holdings
11/22/2024 9:57:28 PM
2x new MANF articles, big summary u (2)
AMBS Amarantus Bioscience Holdings
11/15/2024 11:08:25 AM
2x forthcoming MANF in Kidney Disea (3)
AMBS Amarantus Bioscience Holdings
11/08/2024 11:29:50 AM
Big new research out of NYC on reco (3)
AMBS Amarantus Bioscience Holdings
10/21/2024 5:06:08 PM
Two new MANF research articles in A (3)
AMBS Amarantus Bioscience Holdings
10/14/2024 11:52:38 PM
Dr. Urano October Update October 14 (3)
AMBS Amarantus Bioscience Holdings
10/05/2024 8:01:07 PM
New: MANF in Liver Regeneration MAN (3)
AMBS Amarantus Bioscience Holdings
09/17/2024 8:26:29 PM
Gerald is still tending. It's winte (2)
AMBS Amarantus Bioscience Holdings
09/01/2024 12:38:38 PM
Dr. Urano Autumn update: "Regenerat (3)
AMBS Amarantus Bioscience Holdings
07/16/2024 1:19:35 PM
Z trades? Interesting to see these
AMBS Amarantus Bioscience Holdings
07/11/2024 11:56:37 AM
New MANF Research on Spinal and bul (3)
AMBS Amarantus Bioscience Holdings
06/05/2024 3:42:23 AM
3x MANF research articles: Cervical (3)
AMBS Amarantus Bioscience Holdings
05/25/2024 8:36:05 AM
New MANF Research in Liver Cancer R (2)
AMBS Amarantus Bioscience Holdings
05/09/2024 8:02:35 AM
2x new MANF articles 1) Mesencephal (2)
AMBS Amarantus Bioscience Holdings
05/01/2024 6:08:23 PM
Judgement against Magna is out. In (2)
AMBS Amarantus Bioscience Holdings
04/02/2024 9:45:37 AM
You need a Pacer account. There is
AMBS Amarantus Bioscience Holdings
03/29/2024 8:59:33 PM
Magna Update: issues were resolved (5)
AMBS Amarantus Bioscience Holdings
03/05/2024 6:51:19 AM
Emerald Biotherapeutics is a Delawa (3)
AMBS Amarantus Bioscience Holdings
03/05/2024 6:33:24 AM
Funi Urano Wolframs presentation at (2)
AMBS Amarantus Bioscience Holdings
03/02/2024 5:29:12 AM
Next update March 29. Negotiating s (3)
AMBS Amarantus Bioscience Holdings
02/18/2024 3:06:36 AM
Friggin lawyers man (1)
AMBS Amarantus Bioscience Holdings
02/17/2024 3:35:33 AM
Next update March 1 February 16, 20 (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Aeroméxico's Exciting Global Offering: What You Need to Know
  • Investigation Into Luminar Technologies Signals Serious Concerns
  • Inquiry into Hasbro Leadership: Legal Investigation Unfolds
  • Legal Investigation of CVS/Aetna Medicare Advantage Claims
  • Deadline Approaches for Dow Investors in Class Action Case
  • Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
  • Fluor Corporation Lawsuit Update: Important Investor Info
  • Investors Urged to Act Before KBR Class Action Deadline
  • Cytokinetics Class Action Lawsuit Update: Important Deadlines
  • Important Legal Update for WPP Investors: Key Deadline Approaches
  • Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
  • Marex Group Faces Class Action Lawsuit Over Financial Misconduct
  • Lead the Charge: Join the Fly-E Group Securities Lawsuit
  • Investigation into MoonLake Immunotherapeutics Raises Concerns
  • MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
  • Investigation of MoonLake Immunotherapeutics Raises Concerns
  • Leadership Changes at Silver Mountain Resources: What to Expect
  • Canton Fair Launches Enhanced Services to Boost Global Trade
  • rYojbaba's Global Outreach: Enhancing Health and Legal Aid Services
  • Empowering Conversations on Motherhood and Health Initiatives
  • The Wealth Growth Journey of Insight Enterprises Stock
  • Exploring Sterling Infrastructure's Impressive Stock Growth Over 15 Years
  • Flagstar Bank, N.A. Completes Strategic Holding Company Shift
  • Baxter International Inc. Faces Class Action Lawsuit Challenges
  • StoneX Enhances Wealth Management Services for Latin America
  • The Impact of Long-Term Investment in Commercial Metals
  • Transforming Healthcare Marketing: Salubrum's AI Innovation
  • StoneX Enhances Wealth Management for Latin American Clients
  • The Growth Journey of Tapestry: A Decade in Review
  • Quantum Corporation Investors Urged to Act Before Deadline
  • WhippleWood CPAs Partners to Transform Client Engagement with Tech
  • Investing in First Solar Stock: A Five-Year Review
  • Mirror Lake Inn Resort and Spa: Northeast's Top Choice for Luxury
  • United Lithium's Strategic Acquisition to Enhance Market Position
  • PeopleGuru Holdings Faces Legal Action After Data Breach Incident
  • The Remarkable Growth of Comfort Systems USA Investments
  • Zions Bancorporation Under Investigation: Key Facts for Investors
  • United Lithium's Strategic Move to Enhance Nordic Metals Portfolio
  • Understanding the Historic Growth of United Rentals Stock
  • Legal Inquiry Launched for Merger Investigation of Major Firms
  • GRAIL's PATHFINDER 2 Study Revolutionizes Early Cancer Detection
  • Investors Alert: Tronox Holdings PLC Class Action Reminders
  • Understanding Spotify Technology's Investment Growth Over Time
  • How $100 in Canadian Natural Resources Grows Over 5 Years
  • Baxter International Faces Class Action from Investors Amid Concerns
  • Understanding Jacobs Solutions: A Price-to-Earnings Analysis
  • Virtual Field Surpasses 4 Million Eye Exams Transforming Diagnostics
  • Welltower's Remarkable Growth: $100 Investment Today Worth $1571
  • Marex Group PLC Shareholders: Class Action Info and Updates
  • FDA Approval for Rybelsus®: A Game Changer for Diabetes Care
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site